Rinn Pharma & Biopharma’s transdisciplinary research programme focuses on two core challenges in drug development. The first: creation of patient-centred medicines that meet the needs of diverse patient groups, including the development and manufacture of complex formulations that improve drug effectiveness, acceptability, and dosing. The second: integration of sustainability into all stages of drug development and manufacturing, aiming to reduce the environmental impact of pharmaceutical processes such as synthesis, formulation, and bioprocessing. Rinn Pharma & Biopharma will build the scientific foundation, talent pipeline, and collaborative community needed to address these challenges.
Director: Professor Damien Thompson, University of Limerick
Radical collaboration with: Dublin City University, Munster Technological University, Maynooth University, National Institute for Bioprocessing Research and Training, RCSI University of Medicine and Health Sciences, South East Technological University: Midlands Midwest, Trinity College Dublin, Tyndall National Institute, University College Cork, University College Dublin University of Galway, University of Limerick.